Peter S. Benton Joins Worldwide Clinical Trials as President, COO

Share Article

WCT facilitates the development of life-changing medicines by integrating clinical trials methodology, operational acumen, and efficient technology.

The culture of scientific excellence ... executed via our seamless operational platform makes WCT an ideal environment for the smartest people in the industry to thrive."

Peter S. Benton, MBA, has joined Worldwide Clinical Trials, a world-class CRO relentless in customer focus, driven by global operational excellence integrated with acknowledged medical and scientific expertise.

As President and Chief Operating Officer, Benton is responsible for leading WCT on its mission to facilitate the development of life-changing medicines by integrating clinical trials methodology, operational acumen and efficient technology.

“I am so excited to be part of a great worldwide organization that is so focused on top-notch customer satisfaction in the context of clinical research. It’s a passion of mine and our global team. The culture of scientific excellence, grounded with a medical perspective and executed via our seamless, operational platform makes WCT an ideal environment for the smartest people in the industry to thrive,” Benton said.

Benton has a diverse background with significant senior executive level experience. He joins WCT from BioClinica, having served as EVP and president for their eClinical Solutions business, where he led overall strategy, sales and operations and drove the company to grow by more than 300%. Prior to joining BioClinica, Benton was the chief operating officer of a provider of clinical trials software and services. Additional experience includes founding a medical device company called Flexible Medical Systems. In addition, he managed late stage drug development as vice president at a large, global pharmaceutical company, and has held various management positions in M&A, strategy and operations.

“The addition of Peter Benton to the senior management of our organization indicates the continued evolution of WCT as a customer-focused, technologically sophisticated, global drug development partner for the biopharmaceutical industry,” said Dr. Neal Cutler, CEO of WCT.

“Additionally, because of Peter’s experience in building and implementing a first-rate operational infrastructure, supported by enabling technologies, Peter will provide a truly exceptional business platform that can only enhance the very strong medical and scientific reputation that is the hallmark of the WCT organization,” said Dr. Michael F. Murphy, Chief Medical and Scientific Officer.

Benton graduated cum laude with a Bachelor’s degree in Mechanical Engineering from Northeastern University and holds an MBA in Finance and Strategy from The Wharton School, University of Pennsylvania. He is chairman of Flexible Medical Systems and a member of the Microsoft Healthcare Partner Executive Board.

About WCT
Worldwide Clinical Trials is a global CRO providing full-service drug development services to the biopharmaceutical industry from Early Phase and Bioanalytical Sciences through Phase II and III trials to Peri-Approval studies. We believe successful drug development strategically balances science, medicine, operations and commercial intelligence. Our mission is to foster the development of life changing medicines by integrating clinical methodology, operational acumen and efficient technology.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kerry Hutchings
Visit website